A study of S-033188 for the treatment of Influenza virus infections.
Phase of Trial: Phase I
Latest Information Update: 01 Aug 2016
At a glance
- Drugs S 033188 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 01 Aug 2016 According to a company website, this trial is planned in August 2016.
- 01 Aug 2016 New trial record